PathVysion HER-2 DNA Probe Kit

FDA Premarket Approval P980024 S022

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

DevicePathVysion HER-2 DNA Probe Kit
Generic NameSystem, Test, Her-2/neu, Nucleic Acid Or Serum
ApplicantABBOTT MOLECULAR, INC.1300 East Touhy Avenuedes Plaines, IL 60018 PMA NumberP980024 Supplement NumberS022 Date Received02/18/2022 Decision Date03/18/2022 Product Code MVD  Advisory Committee Pathology Supplement Type30-day Notice Supplement Reason Process Change - Manufacturer/sterilizer/packager/supplier Expedited Review Granted? No
Date Received2022-02-18
Decision Date2022-03-18
PMAP980024
SupplementS022
Product CodeMVD 
Advisory CommitteePathology
Supplement Type30-day Notice
Supplement ReasonProcess Change - Manufacturer/sterilizer/packager/supplier
Expedited ReviewNo
Combination ProductNo
Applicant AddressABBOTT MOLECULAR, INC.
1300 East Touhy Avenue
des Plaines, IL 60018 PMA NumberP980024 Supplement NumberS022 Date Received02/18/2022 Decision Date03/18/2022 Product Code MVD  Advisory Committee Pathology Supplement Type30-day Notice Supplement Reason Process Change - Manufacturer/sterilizer/packager/supplier Expedited Review Granted? No Combination ProductNo Approval Order Statement  
an Extension Of Expiration Dating Of Certain Assay Pretreatment Reagent Kit Components

Supplemental Filings

Supplement NumberDateSupplement Type
P980024Original Filing
S022 2022-02-18 30-day Notice
S021 2020-11-16 30-day Notice
S020 2019-04-10 30-day Notice
S019 2018-08-10 30-day Notice
S018 2018-06-15 30-day Notice
S017 2018-02-16 30-day Notice
S016 2017-11-08 30-day Notice
S015 2016-09-02 30-day Notice
S014 2016-06-01 30-day Notice
S013 2014-06-16 30-day Notice
S012 2013-11-25 30-day Notice
S011 2013-11-05 30-day Notice
S010 2013-01-16 30-day Notice
S009 2012-11-15 30-day Notice
S008 2012-06-21 Special (immediate Track)
S007 2012-06-14 135 Review Track For 30-day Notice
S006 2011-10-17 135 Review Track For 30-day Notice
S005 2011-02-22 135 Review Track For 30-day Notice
S004 2010-12-22 30-day Notice
S003 2009-01-15 30-day Notice
S002 2005-06-20 Normal 180 Day Track No User Fee
S001 2001-03-30 Panel Track

NIH GUDID Devices

Device IDPMASupp
00884999001763 P980024 001
00884999001756 P980024 001
00884999001732 P980024 001

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.